Guardant Health (NASDAQ: GH) director sells 1,700 shares after option exercise
Rhea-AI Filing Summary
Guardant Health director Manuel Hidalgo Medina exercised stock options for 950 shares on August 5, 2026 at an exercise price of $32.5500 per share, receiving 950 common shares. He then sold 1,700 common shares in two trades at $163.9450 and $164.6051 per share. After the exercise, he continued to hold stock options covering 12,079 shares that were granted on July 17, 2024 and vest 25% on July 17, 2025, with the remaining 75% vesting monthly over the following three years.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Hidalgo Medina Manuel
Role
Director
Sold
1,700 shs ($279K)
Approx. gross sale proceeds
$279K
Approx. exercise cost
$31K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 950 | $0.00 | $0.00 |
| Exercise | Common Stock | 950 | $32.55 | $31K |
| Sale | Common Stock | 950 | $163.945 | $156K |
| Sale | Common Stock | 750 | $164.6051 | $123K |
Holdings After Transaction:
Stock Option (Right to Buy) — 12,079 shares (Direct);
Common Stock — 4,556 shares (Direct)
Footnotes (1)
- F1. The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
Key Figures
Shares sold at $163.9450: 950 shares
Shares sold at $164.6051: 750 shares
Total shares sold: 1,700 shares
+4 more
7 metrics
Shares sold at $163.9450
950 shares
Common Stock sale on 2026-08-05 at $163.9450 per share
Shares sold at $164.6051
750 shares
Common Stock sale on 2026-08-05 at $164.6051 per share
Total shares sold
1,700 shares
Aggregate Common Stock sales on 2026-08-05
Shares acquired via option exercise
950 shares
Stock Option (Right to Buy) exercised at $32.5500 on 2026-08-05
Option exercise price
$32.5500 per share
Conversion or exercise price of Stock Option (Right to Buy)
Options held after exercise
12079 shares
Total shares underlying Stock Option (Right to Buy) following exercise
Option expiration date
2034-07-17
Expiration date of the Stock Option (Right to Buy) grant
Key Terms
Stock Option (Right to Buy), derivative security, vests over a four-year period
3 terms
Stock Option (Right to Buy) financial
"Security title reported as Stock Option (Right to Buy)"
derivative security financial
"Transaction code M described as Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vests over a four-year period financial
"The stock option granted on July 17, 2024 vests over a four-year period"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did GH director Manuel Hidalgo Medina report on August 5, 2026?
Manuel Hidalgo Medina reported exercising options for 950 Guardant Health (GH) shares at $32.5500 and then selling 1,700 common shares in two trades at $163.9450 and $164.6051 per share, all dated August 5, 2026.
What stock options did the GH director exercise in this Form 4 filing?
He exercised a Stock Option (Right to Buy) for 950 shares of Guardant Health common stock at an exercise price of $32.5500 per share. The option expires on July 17, 2034 and was part of a 2024 grant with multi-year vesting.
How many Guardant Health (GH) stock options does the director hold after these transactions?
Following the reported option exercise, he continued to hold stock options for 12,079 shares of Guardant Health common stock. These options relate to a grant dated July 17, 2024, which vests over a four-year period through monthly installments.
What is the vesting schedule of the Guardant Health (GH) stock option mentioned in the Form 4?
The stock option granted on July 17, 2024 vests over four years: 25% of the shares vested on July 17, 2025, and the remaining 75% vests in equal monthly installments over the following three years, subject to continued service.